Provided by Tiger Fintech (Singapore) Pte. Ltd.

Innate Pharma SA

2.04
+0.04502.26%
Volume:18.67K
Turnover:37.36K
Market Cap:170.98M
PE:-4.51
High:2.05
Open:1.99
Low:1.96
Close:2.00
Loading ...
Sep 11, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Apr 04, 2024

Annual Report

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
Jan 12, 2024

Correspondence

Form CORRESP - Correspondence
Apr 20, 2023

[Rev.]Annual Report

20-F/A [Amend] - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
Apr 06, 2023

Annual Report

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
Dec 06, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Oct 21, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Apr 04, 2022

Annual Report

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
Jul 12, 2021

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
May 11, 2021

important event

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Apr 27, 2021

Annual Report

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
Mar 16, 2021

important event

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Feb 12, 2021

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
Jan 27, 2021

Correspondence

CORRESP [Cover] - Correspondence
Apr 24, 2020

Annual Report

Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
Apr 14, 2020

Report of foreign issuer

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]